Mersana Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/29/2026

1. LFTO
2. CMCSA
3. QNT
4. NVDA
5. VRDN
6. INIO
7. HONA
8. ABBV
9. SPY
10. HON

Go back to Mersana Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results

Mersana Therapeutics (MRSN) Tops Q3 EPS by 1c

November 7, 2023 7:08 AM EST

Mersana Therapeutics (NASDAQ: MRSN) reported Q3 EPS of ($0.35), $0.01 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $7.7 million versus the consensus estimate of $9.3 million.

For earnings history and earnings-related data on Mersana Therapeutics (MRSN) click here.

... More